For COVID-Impacted Studies, FDA Loosens Video Conferencing Rules
Executive Summary
Use of alternative labs or imaging centers depends upon type of assessment and reason it is being performed, the US agency's revised guidance states; missed milestones for postmarketing studies required under accelerated approval will need to be justified.